תבנית:תרופה/קרבדקסון 12.5 - Carvedexxon 12.5

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×§×¨×××§×¡×× 6.25 - Carvedexxon 6.25
×§×××¦× ×¤×¨××§××××××ª (ATC4)	C07AG Alpha and beta blocking agents
××¨××× ×¤×¢×× (ATC5)	Â Carvedilol 12.5MG âC07AG02
×¦××¨×ª ××ª×	×¤××× - PER OS
×¦××¨×ª ××× ××	×××××, TABLETS ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Treatment of symptomatic congestive heart failure. Carvedexxon may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ACE inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/×§×¨×××§×¡×× 12.5 - Carvedexxon 12.5
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 30.04.2017 Â ××××¨× ××¢××× 27.03.2017 ××××¨× ××¢××× 12.08.2012 (××¡×× Microsoft Word)

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 31.03.2017 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.03.2017 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 31.03.2017

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×§×¨×××§×¡×× 12.5 ×××××¨ ××©×¨× ×××¨××××ª

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/×§×¨×××§×¡×× 12.5 - Carvedexxon 12.5}}

×:

{{×ª×¨××¤×/×§×¨×××§×¡×× 12.5 - Carvedexxon 12.5
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־7 באפריל 2023 ב־16:43

ויקיתרופות